Finding methods of successfully treating cancer has been one of the biggest challenges of the 21st century. Worldwide, an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths occurred in 2020 (GLOBOCAN 2020). According to estimates from the World Health Organisation (WHO) in 2019, cancer is the first or second leading cause of death in people below the age of 70 in 112 of 183 countries and ranks third or fourth in a further 23 countries. Crucially, the global cancer burden is expected to be 28.4 million cases in 2040, a 47% rise from 2020. A significant increase in knowledge surrounding oncogenesis, risk factors and drivers of cancer development over the last two decades, has resulted in the development of new, more targeted treatments. Oncological treatments are increasing utilising specific targets within the cancer cell to engineer more effective treatment of particular types of cancer. Recent development of new technologies has also played a key role in personalising treatments and could bring significant differences in the patients’ cure outcomes. This webinar explores CAR-T cell Therapy and Robotic Surgery as two of those innovative approaches, which can give cancer patients better chances for the best possible outcome. CAR-T Cell Therapy aims to fit the treatment according to each patient’s specific needs using their own immune T-cells and genetically engineering them to target a specific cancer antigen. Whereas Robotic Surgery represents hope for patients for whom classic surgery may not be possible. The robot-assisted and 3-D imaging technology allows surgeons to perform complex surgeries with more precision than conventional techniques. Let’s dive into the music of the future!
Stavroula Chante, YCN representative, UK
Selma Islamčević, YCN representative, Croatia
CAR-T Cell Therapy: Bradley Dixon, MD
Robotic Surgery: Danko Kostadinov, MD, PhD., UK
REGISTRATION LINK: Meeting Registration – Zoom